Newmont (NYSE: NEM) MD Rodgers sells 2,051 shares, gets 1,361-share award
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Newmont Corp executive Mark C. Rodgers, MD, Africa-Asia Pacific, reported mixed equity activity. He completed an open-market sale of 2,051 shares of common stock at $131.14 per share on March 2, 2026, under a pre-established Rule 10b5-1 trading plan dated November 24, 2025.
Earlier, on February 27, 2026, he acquired 1,361 shares of common stock through a grant or award at no cost. Following the March 2 sale, Rodgers directly held 27,117 shares of Newmont common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 2,051 shares ($268,968)
Net Sell
2 txns
Insider
Rodgers Mark C
Role
MD, Africa-Asia Pacific
Sold
2,051 shs ($269K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock, $1.60 par value | 2,051 | $131.14 | $269K |
| Grant/Award | Common Stock, $1.60 par value | 1,361 | $0.00 | -- |
Holdings After Transaction:
Common Stock, $1.60 par value — 27,117 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transactions did Mark C. Rodgers report for NEWMONT (NEM)?
Mark C. Rodgers reported two transactions: an open-market sale of 2,051 Newmont common shares on March 2, 2026, and an acquisition of 1,361 shares via grant or award on February 27, 2026. Both positions are held as direct ownership.
What type of acquisition did Mark C. Rodgers report for NEWMONT (NEM) stock?
Rodgers reported acquiring 1,361 Newmont common shares on February 27, 2026 as a grant, award, or other acquisition. The shares were recorded at a price of $0.00 per share, indicating a compensation-related equity award rather than an open-market purchase.